Key to 400-employee Denali's submission is the FDA allowing measurement of a type of GAG, called heparan sulfate, in ...

Protagonist (Nasdaq: PTGX) is one of a handful of Bay Area drug developers ready to ask the Food and Drug Administration to ...

Vence Bonham Jr., the highest ranking official at the National Human Genome Research Institute (NHGRI), has been put on ...

The excitement late last year over U.S. President Donald Trump's election victory and prospects for a subsequent flurry of mergers and acquisition deals have quickly faded, they say ...

Researchers have engineered yeast to efficiently convert methanol into D-lactic acid, a key compound for biodegradable ...

CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing ...

This development marks a crucial step forward in SMSbiotech’s efforts to address this debilitating respiratory condition. The Phase I trial, conducted in Australia, will be the first human trial of ...

In a significant move announced in late 2024, Sana Biotechnology has pivoted its strategy to focus primarily on its Type 1 Diabetes (T1D) and Autoimmune Disease (AID) programs. This decision led ...

MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that the ...

SEATTLE & CAMBRIDGE, Mass & TOKYO--(BUSINESS WIRE)--Aurion Biotech, Inc. (Aurion Biotech), whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today ...